Insiders · Profile

Patel Anish

CHIEF OPERATING OFFICER at Enliven Therapeutics. Filing since 22 Dec 2023. CIK 0001967163

Company

Date

Role

Action

Shares

Amount

Of holding

ELVN Enliven Therapeutics, Inc.

9 Jan 2026

CHIEF OPERATING OFFICER

Sold on a plan

48,300

$1.35M

18.3%

ELVN Enliven Therapeutics, Inc.

8 Dec 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,663

$140.07K

2.5%

ELVN Enliven Therapeutics, Inc.

7 Nov 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$116.03K

2.4%

ELVN Enliven Therapeutics, Inc.

7 Oct 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$133.99K

2.4%

ELVN Enliven Therapeutics, Inc.

8 Sep 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$134.96K

2.3%

ELVN Enliven Therapeutics, Inc.

7 Aug 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$121.62K

2.2%

ELVN Enliven Therapeutics, Inc.

7 Jul 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$131.95K

2.2%

ELVN Enliven Therapeutics, Inc.

9 Jun 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$135.57K

2.2%

ELVN Enliven Therapeutics, Inc.

7 May 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$122.58K

2.1%

ELVN Enliven Therapeutics, Inc.

7 Apr 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$120.27K

2.1%

ELVN Enliven Therapeutics, Inc.

7 Mar 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$142.94K

2.0%

ELVN Enliven Therapeutics, Inc.

7 Feb 2025

CHIEF OPERATING OFFICER

Sold at will

6,667

$146.21K

2.0%

ELVN Enliven Therapeutics, Inc.

7 Jan 2025

CHIEF OPERATING OFFICER

Sold on a plan

21,700

$524.70K

100%

ELVN Enliven Therapeutics, Inc.

7 Jan 2025

CHIEF OPERATING OFFICER

Sold on a plan

6,667

$161.17K

1.9%

ELVN Enliven Therapeutics, Inc.

18 Oct 2024

CHIEF OPERATING OFFICER

Sold on a plan

716

$21.48K

0.2%

ELVN Enliven Therapeutics, Inc.

16 Jul 2024

CHIEF OPERATING OFFICER

Sold on a plan

1,547

$38.69K

0.4%

ELVN Enliven Therapeutics, Inc.

15 Jul 2024

CHIEF OPERATING OFFICER

Sold on a plan

30,978

$776.04K

8.2%

ELVN Enliven Therapeutics, Inc.

12 Jul 2024

CHIEF OPERATING OFFICER

Sold on a plan

17,475

$438.09K

4.4%

ELVN Enliven Therapeutics, Inc.

6 Jun 2024

CHIEF OPERATING OFFICER

Sold on a plan

1,133

$22.72K

100%

ELVN Enliven Therapeutics, Inc.

14 May 2024

CHIEF OPERATING OFFICER

Sold on a plan

1,107

$27.68K

100%

ELVN Enliven Therapeutics, Inc.

9 May 2024

CHIEF OPERATING OFFICER

Sold on a plan

260

$6.52K

100%

ELVN Enliven Therapeutics, Inc.

6 May 2024

CHIEF OPERATING OFFICER

Sold on a plan

4,875

$110.77K

100%

ELVN Enliven Therapeutics, Inc.

11 Apr 2024

CHIEF OPERATING OFFICER

Sold on a plan

17,500

$438.10K

100%

ELVN Enliven Therapeutics, Inc.

8 Apr 2024

CHIEF OPERATING OFFICER

Sold on a plan

4,875

$90.69K

65.2%

ELVN Enliven Therapeutics, Inc.

6 Mar 2024

CHIEF OPERATING OFFICER

Sold on a plan

4,875

$76.24K

39.5%

ELVN Enliven Therapeutics, Inc.

6 Feb 2024

CHIEF OPERATING OFFICER

Sold on a plan

4,875

$73.66K

28.3%

ELVN Enliven Therapeutics, Inc.

22 Jan 2024

Chief Operating Officer

Sold on a plan

4,875

$73.78K

22.1%

ELVN Enliven Therapeutics, Inc.

2 Jan 2024

Chief Operating Officer

Sold on a plan

11,000

$165.05K

33.2%

ELVN Enliven Therapeutics, Inc.

29 Dec 2023

Chief Operating Officer

Sold on a plan

20

$300.00

0.1%

ELVN Enliven Therapeutics, Inc.

28 Dec 2023

Chief Operating Officer

Sold on a plan

2,520

$38.00K

7.1%

ELVN Enliven Therapeutics, Inc.

26 Dec 2023

Chief Operating Officer

Sold on a plan

102

$1.53K

0.3%

ELVN Enliven Therapeutics, Inc.

22 Dec 2023

Chief Operating Officer

Sold on a plan

983

$14.78K

2.7%

32 decisions on file.